Dimethylformamide → 2-Methoxy-5-(2-oxo-propoxy)-benzoic acid methyl ester
Reaction equation
O[C:2]1[CH:11]=[CH:10][C:5]([C:6]([O:8][CH3:9])=[O:7])=[C:4]([O:12][CH3:13])[CH:3]=1.Cl[CH2:15][C:16](=[O:18])[CH3:17].C(=O)([O-])[O-:20].[K+].[K+].CN(C)C=O>C(OCC)(=O)C>[CH3:9][O:8][C:6](=[O:7])[C:5]1[CH:10]=[C:11]([O:20][CH2:15][C:16](=[O:18])[CH3:17])[CH:2]=[CH:3][C:4]=1[O:12][CH3:13]Participants
6
Procedure
Stir a mixture of methyl 4-hydroxy-2-methoxybenzoate (Danishefsky et al., J. Med. Chem. 1979, 101, 7001-7008, 0.54 g, 3 mmol), chloroacetone (6 mmol, Aldrich Chemical Company), potassium carbonate (9 mmol) and dimethylformamide at 50° C. overnight. Cool the reaction to room temperature, dilute with ethyl acetate, wash with saturated NaHCO3 solution and saturated brine. Dry (MgSO4) the organic phase, filter and concentrate the filtrate in vacuo. Purify the residue by column chromatography (silica gel, step gradient elution with 10% ethyl acetate in hexane to 30% ethyl acetate in hexane) and concentrate the appropriate fractions to afford 0.73 g of 2-methoxy-5-(2-oxo-propoxy)-benzoic acid methyl ester.
Workup
- temperatureCool
- customthe reaction to room temperature
- washwash with saturated NaHCO3 solution and saturated brine
- dry with materialDry (MgSO4) the organic phase
- filtrationfilter
- concentrationconcentrate the filtrate in vacuo
- customPurify the residue
- washby column chromatography (silica gel, step gradient elution with 10% ethyl acetate in hexane to 30% ethyl acetate in hexane)
- concentrationconcentrate the appropriate fractions
Sources & evidence
- ORD record
- ord-1581841cd0e24037afa5288adb5d6351
- Source dataset
- uspto-grants-2002_07
- Patent number
- US06423704B1
Reaction notes
Loading…